Skip to main content
Research examines cost-effectiveness of CGM in diabetes
4/16/2018

A study in Diabetes Care showed that the use of continuous glucose monitoring had an incremental cost-effectiveness ratio of $98,108/quality-adjusted life year and resulted in reductions in A1C, daily test strip use and daily rate of non-severe hypoglycemia events among type 1 diabetes patients with an A1C of at least 7.5%, compared with the control group. Researchers used a cohort of 158 patients and found that both groups had similar QALY over six months.

Full Story: